Copyright Reports & Markets. All rights reserved.

Global Infectious Disease POC Diagnostic Market Growth 2022-2028

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Infectious Disease POC Diagnostic Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for Infectious Disease POC Diagnostic by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for Infectious Disease POC Diagnostic by Country/Region, 2017, 2022 & 2028
  • 2.2 Infectious Disease POC Diagnostic Segment by Type
    • 2.2.1 Lateral Flow Immunoassay
    • 2.2.2 Agglutination Test
    • 2.2.3 Flow-Through Test
    • 2.2.4 Molecular Diagnostics
    • 2.2.5 Others
  • 2.3 Infectious Disease POC Diagnostic Sales by Type
    • 2.3.1 Global Infectious Disease POC Diagnostic Sales Market Share by Type (2017-2022)
    • 2.3.2 Global Infectious Disease POC Diagnostic Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global Infectious Disease POC Diagnostic Sale Price by Type (2017-2022)
  • 2.4 Infectious Disease POC Diagnostic Segment by Application
    • 2.4.1 Hospital Bedside
    • 2.4.2 Urgent Care and Retail Clinics
    • 2.4.3 Home and Self-Testing
    • 2.4.4 Others
  • 2.5 Infectious Disease POC Diagnostic Sales by Application
    • 2.5.1 Global Infectious Disease POC Diagnostic Sale Market Share by Application (2017-2022)
    • 2.5.2 Global Infectious Disease POC Diagnostic Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global Infectious Disease POC Diagnostic Sale Price by Application (2017-2022)

3 Global Infectious Disease POC Diagnostic by Company

  • 3.1 Global Infectious Disease POC Diagnostic Breakdown Data by Company
    • 3.1.1 Global Infectious Disease POC Diagnostic Annual Sales by Company (2020-2022)
    • 3.1.2 Global Infectious Disease POC Diagnostic Sales Market Share by Company (2020-2022)
  • 3.2 Global Infectious Disease POC Diagnostic Annual Revenue by Company (2020-2022)
    • 3.2.1 Global Infectious Disease POC Diagnostic Revenue by Company (2020-2022)
    • 3.2.2 Global Infectious Disease POC Diagnostic Revenue Market Share by Company (2020-2022)
  • 3.3 Global Infectious Disease POC Diagnostic Sale Price by Company
  • 3.4 Key Manufacturers Infectious Disease POC Diagnostic Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers Infectious Disease POC Diagnostic Product Location Distribution
    • 3.4.2 Players Infectious Disease POC Diagnostic Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Infectious Disease POC Diagnostic by Geographic Region

  • 4.1 World Historic Infectious Disease POC Diagnostic Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global Infectious Disease POC Diagnostic Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global Infectious Disease POC Diagnostic Annual Revenue by Geographic Region
  • 4.2 World Historic Infectious Disease POC Diagnostic Market Size by Country/Region (2017-2022)
    • 4.2.1 Global Infectious Disease POC Diagnostic Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global Infectious Disease POC Diagnostic Annual Revenue by Country/Region
  • 4.3 Americas Infectious Disease POC Diagnostic Sales Growth
  • 4.4 APAC Infectious Disease POC Diagnostic Sales Growth
  • 4.5 Europe Infectious Disease POC Diagnostic Sales Growth
  • 4.6 Middle East & Africa Infectious Disease POC Diagnostic Sales Growth

5 Americas

  • 5.1 Americas Infectious Disease POC Diagnostic Sales by Country
    • 5.1.1 Americas Infectious Disease POC Diagnostic Sales by Country (2017-2022)
    • 5.1.2 Americas Infectious Disease POC Diagnostic Revenue by Country (2017-2022)
  • 5.2 Americas Infectious Disease POC Diagnostic Sales by Type
  • 5.3 Americas Infectious Disease POC Diagnostic Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Infectious Disease POC Diagnostic Sales by Region
    • 6.1.1 APAC Infectious Disease POC Diagnostic Sales by Region (2017-2022)
    • 6.1.2 APAC Infectious Disease POC Diagnostic Revenue by Region (2017-2022)
  • 6.2 APAC Infectious Disease POC Diagnostic Sales by Type
  • 6.3 APAC Infectious Disease POC Diagnostic Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe Infectious Disease POC Diagnostic by Country
    • 7.1.1 Europe Infectious Disease POC Diagnostic Sales by Country (2017-2022)
    • 7.1.2 Europe Infectious Disease POC Diagnostic Revenue by Country (2017-2022)
  • 7.2 Europe Infectious Disease POC Diagnostic Sales by Type
  • 7.3 Europe Infectious Disease POC Diagnostic Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Infectious Disease POC Diagnostic by Country
    • 8.1.1 Middle East & Africa Infectious Disease POC Diagnostic Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa Infectious Disease POC Diagnostic Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa Infectious Disease POC Diagnostic Sales by Type
  • 8.3 Middle East & Africa Infectious Disease POC Diagnostic Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of Infectious Disease POC Diagnostic
  • 10.3 Manufacturing Process Analysis of Infectious Disease POC Diagnostic
  • 10.4 Industry Chain Structure of Infectious Disease POC Diagnostic

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 Infectious Disease POC Diagnostic Distributors
  • 11.3 Infectious Disease POC Diagnostic Customer

12 World Forecast Review for Infectious Disease POC Diagnostic by Geographic Region

  • 12.1 Global Infectious Disease POC Diagnostic Market Size Forecast by Region
    • 12.1.1 Global Infectious Disease POC Diagnostic Forecast by Region (2023-2028)
    • 12.1.2 Global Infectious Disease POC Diagnostic Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global Infectious Disease POC Diagnostic Forecast by Type
  • 12.7 Global Infectious Disease POC Diagnostic Forecast by Application

13 Key Players Analysis

  • 13.1 F. Hoffmann-La Roche
    • 13.1.1 F. Hoffmann-La Roche Company Information
    • 13.1.2 F. Hoffmann-La Roche Infectious Disease POC Diagnostic Product Offered
    • 13.1.3 F. Hoffmann-La Roche Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 F. Hoffmann-La Roche Main Business Overview
    • 13.1.5 F. Hoffmann-La Roche Latest Developments
  • 13.2 Thermo Fisher Scientific
    • 13.2.1 Thermo Fisher Scientific Company Information
    • 13.2.2 Thermo Fisher Scientific Infectious Disease POC Diagnostic Product Offered
    • 13.2.3 Thermo Fisher Scientific Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 Thermo Fisher Scientific Main Business Overview
    • 13.2.5 Thermo Fisher Scientific Latest Developments
  • 13.3 Abbott Laboratories
    • 13.3.1 Abbott Laboratories Company Information
    • 13.3.2 Abbott Laboratories Infectious Disease POC Diagnostic Product Offered
    • 13.3.3 Abbott Laboratories Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 Abbott Laboratories Main Business Overview
    • 13.3.5 Abbott Laboratories Latest Developments
  • 13.4 Quest Diagnostics
    • 13.4.1 Quest Diagnostics Company Information
    • 13.4.2 Quest Diagnostics Infectious Disease POC Diagnostic Product Offered
    • 13.4.3 Quest Diagnostics Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 Quest Diagnostics Main Business Overview
    • 13.4.5 Quest Diagnostics Latest Developments
  • 13.5 BD
    • 13.5.1 BD Company Information
    • 13.5.2 BD Infectious Disease POC Diagnostic Product Offered
    • 13.5.3 BD Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 BD Main Business Overview
    • 13.5.5 BD Latest Developments
  • 13.6 bioMérieux
    • 13.6.1 bioMérieux Company Information
    • 13.6.2 bioMérieux Infectious Disease POC Diagnostic Product Offered
    • 13.6.3 bioMérieux Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 bioMérieux Main Business Overview
    • 13.6.5 bioMérieux Latest Developments
  • 13.7 Cardinal Health
    • 13.7.1 Cardinal Health Company Information
    • 13.7.2 Cardinal Health Infectious Disease POC Diagnostic Product Offered
    • 13.7.3 Cardinal Health Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.7.4 Cardinal Health Main Business Overview
    • 13.7.5 Cardinal Health Latest Developments
  • 13.8 Cepheid
    • 13.8.1 Cepheid Company Information
    • 13.8.2 Cepheid Infectious Disease POC Diagnostic Product Offered
    • 13.8.3 Cepheid Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.8.4 Cepheid Main Business Overview
    • 13.8.5 Cepheid Latest Developments
  • 13.9 Trinity Biotech
    • 13.9.1 Trinity Biotech Company Information
    • 13.9.2 Trinity Biotech Infectious Disease POC Diagnostic Product Offered
    • 13.9.3 Trinity Biotech Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.9.4 Trinity Biotech Main Business Overview
    • 13.9.5 Trinity Biotech Latest Developments
  • 13.10 Quidel Corporation
    • 13.10.1 Quidel Corporation Company Information
    • 13.10.2 Quidel Corporation Infectious Disease POC Diagnostic Product Offered
    • 13.10.3 Quidel Corporation Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.10.4 Quidel Corporation Main Business Overview
    • 13.10.5 Quidel Corporation Latest Developments
  • 13.11 Bio-Rad Laboratories
    • 13.11.1 Bio-Rad Laboratories Company Information
    • 13.11.2 Bio-Rad Laboratories Infectious Disease POC Diagnostic Product Offered
    • 13.11.3 Bio-Rad Laboratories Infectious Disease POC Diagnostic Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.11.4 Bio-Rad Laboratories Main Business Overview
    • 13.11.5 Bio-Rad Laboratories Latest Developments

14 Research Findings and Conclusion

As the global economy mends, the 2021 growth of Infectious Disease POC Diagnostic will have significant change from previous year. According to our (LP Information) latest study, the global Infectious Disease POC Diagnostic market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Infectious Disease POC Diagnostic market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Infectious Disease POC Diagnostic market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Infectious Disease POC Diagnostic market, reaching US$ million by the year 2028. As for the Europe Infectious Disease POC Diagnostic landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Infectious Disease POC Diagnostic players cover F. Hoffmann-La Roche, Thermo Fisher Scientific, Abbott Laboratories, and Quest Diagnostics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Disease POC Diagnostic market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Lateral Flow Immunoassay
Agglutination Test
Flow-Through Test
Molecular Diagnostics
Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital Bedside
Urgent Care and Retail Clinics
Home and Self-Testing
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
F. Hoffmann-La Roche
Thermo Fisher Scientific
Abbott Laboratories
Quest Diagnostics
BD
bioMérieux
Cardinal Health
Cepheid
Trinity Biotech
Quidel Corporation
Bio-Rad Laboratories
Buy now